Literature DB >> 27246481

Surgical outcomes of cervical spondylotic myelopathy: an analysis of a national, administrative, longitudinal database.

Anand Veeravagu1, Ian D Connolly1, Layton Lamsam1, Amy Li1, Christian Swinney1, Tej D Azad1, Atman Desai1, John K Ratliff1.   

Abstract

OBJECTIVE The authors performed a population-based analysis of national trends, costs, and outcomes associated with cervical spondylotic myelopathy (CSM) in the United States. They assessed postoperative complications, resource utilization, and predictors of costs, in this surgically treated CSM population. METHODS MarketScan data (2006-2010) were used to retrospectively analyze the complications and costs of different spine surgeries for CSM. The authors determined outcomes following anterior cervical discectomy and fusion (ACDF), posterior fusion, combined anterior/posterior fusion, and laminoplasty procedures. RESULTS The authors identified 35,962 CSM patients, comprising 5154 elderly (age ≥ 65 years) patients (mean 72.2 years, 54.9% male) and 30,808 nonelderly patients (mean 51.1 years, 49.3% male). They found an overall complication rate of 15.6% after ACDF, 29.2% after posterior fusion, 41.1% after combined anterior and posterior fusion, and 22.4% after laminoplasty. Following ACDF and posterior fusion, a significantly higher risk of complication was seen in the elderly compared with the nonelderly (reference group). The fusion level and comorbidity-adjusted ORs with 95% CIs for these groups were 1.54 (1.40-1.68) and 1.25 (1.06-1.46), respectively. In contrast, the elderly population had lower 30-day readmission rates in all 4 surgical cohorts (ACDF, 2.6%; posterior fusion, 5.3%; anterior/posterior fusion, 3.4%; and laminoplasty, 3.6%). The fusion level and comorbidity-adjusted odds ratios for 30-day readmissions for ACDF, posterior fusion, combined anterior and posterior fusion, and laminoplasty were 0.54 (0.44-0.68), 0.32 (0.24-0.44), 0.17 (0.08-0.38), and 0.39 (0.18-0.85), respectively. CONCLUSIONS The authors' analysis of the MarketScan database suggests a higher complication rate in the surgical treatment of CSM than previous national estimates. They found that elderly age (≥ 65 years) significantly increased complication risk following ACDF and posterior fusion. Elderly patients were less likely to experience a readmission within 30 days of surgery. Postoperative complication occurrence, and 30-day readmission were significant drivers of total cost within 90 days of the index surgical procedure.

Entities:  

Keywords:  ACDF = anterior cervical discectomy and fusion; COPD = chronic obstructive pulmonary disease; CPT = Current Procedural Terminology; CSM = cervical spondylotic myelopathy; DVT = deep vein thrombosis; MarketScan; NIS = Nationwide Inpatient Sample; OPLL = ossification of the posterior longitudinal ligament; adverse events; cervical spondylotic myelopathy; costs

Mesh:

Year:  2016        PMID: 27246481     DOI: 10.3171/2016.3.FOCUS1669

Source DB:  PubMed          Journal:  Neurosurg Focus        ISSN: 1092-0684            Impact factor:   4.047


  12 in total

1.  Surgical treatment of multilevel cervical spondylosis in patients with or without a history of syringomyelia.

Authors:  Jörg Klekamp
Journal:  Eur Spine J       Date:  2017-02-11       Impact factor: 3.134

2.  Trends analysis of surgical procedures for cervical degenerative disc disease and myelopathy in patients with tobacco use disorder.

Authors:  Phillip Grisdela; Zorica Buser; Anthony D'Oro; Permsak Paholpak; John C Liu; Jeffrey C Wang
Journal:  Eur Spine J       Date:  2017-05-09       Impact factor: 3.134

3.  Automatic Localization and Brand Detection of Cervical Spine Hardware on Radiographs Using Weakly Supervised Machine Learning.

Authors:  Raman Dutt; Dylan Mendonca; Huai Ming Phen; Samuel Broida; Marzyeh Ghassemi; Judy Gichoya; Imon Banerjee; Tim Yoon; Hari Trivedi
Journal:  Radiol Artif Intell       Date:  2022-01-19

4.  Machine learning-driven identification of novel patient factors for prediction of major complications after posterior cervical spinal fusion.

Authors:  Akash A Shah; Sai K Devana; Changhee Lee; Amador Bugarin; Elizabeth L Lord; Arya N Shamie; Don Y Park; Mihaela van der Schaar; Nelson F SooHoo
Journal:  Eur Spine J       Date:  2021-08-15       Impact factor: 2.721

5.  Anterior vs Posterior Approach in Multilevel Cervical Spondylotic Myelopathy: A Nationwide Propensity-Matched Analysis of Complications, Outcomes, and Narcotic Use.

Authors:  Ravi S Nunna; Syed Khalid; Ryan G Chiu; Rown Parola; Richard G Fessler; Owoicho Adogwa; Ankit I Mehta
Journal:  Int J Spine Surg       Date:  2022-02

Review 6.  Insights Into Oropharyngeal Dysphagia From Administrative Data and Clinical Registries: A Literature Review.

Authors:  Rebecca S Bartlett; Susan L Thibeault
Journal:  Am J Speech Lang Pathol       Date:  2018-05-03       Impact factor: 2.408

7.  National Trends in Demographics and Outcomes Following Cervical Fusion for Cervical Spondylotic Myelopathy.

Authors:  Caroline E Vonck; Joseph E Tanenbaum; Gabriel A Smith; Edward C Benzel; Thomas E Mroz; Michael P Steinmetz
Journal:  Global Spine J       Date:  2017-09-22

8.  Efficacy and Safety of Surgery for Mild Degenerative Cervical Myelopathy: Results of the AOSpine North America and International Prospective Multicenter Studies.

Authors:  Jetan H Badhiwala; Christopher D Witiw; Farshad Nassiri; Muhammad A Akbar; Alireza Mansouri; Jefferson R Wilson; Michael G Fehlings
Journal:  Neurosurgery       Date:  2019-04-01       Impact factor: 4.654

9.  Radiological and Clinical Outcomes of Anterior Cervical Discectomy and Fusion in Older Patients: A Comparative Analysis of Young-Old Patients (Ages 65-74 Years) and Middle-Old Patients (Over 75 Years).

Authors:  Chi Hyung Lee; Dong Wuk Son; Su Hun Lee; Jun Seok Lee; Soon Ki Sung; Sang Weon Lee; Geun Sung Song
Journal:  Neurospine       Date:  2019-07-05

10.  Quality and Safety Improvement in Spine Surgery.

Authors:  Fan Jiang; Jamie R F Wilson; Jetan H Badhiwala; Carlo Santaguida; Michael H Weber; Jefferson R Wilson; Michael G Fehlings
Journal:  Global Spine J       Date:  2020-01-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.